Anna Rooke | Managing Director, Creative Tech Venture Fund

Anna Rooke was the founding CEO of QUT Creative Enterprise Australia (CEA) and led the organisation for over a decade. Under her leadership, CEA established accelerator programs, a coworking space, an annual Creative3 event, business loan and investment programs and the CEA Startup Fund.

Anna created and secured capital for the CEA Startup Fund in 2014 as Australia’s first early stage fund for creative ventures in Australia. She was responsible for the design of due diligence, investment, risk and compliance infrastructure together with the establishment and management of the Investment Committee. Anna was responsible for all portfolio management, fair valuation policy and asset management working closely with Risk & Finance Committees as well as internal and external auditors on the valuation of assets.

Anna took a hands-on management of CEA Startup portfolio including as a Board member for TrademarkVision, Metaverse Makeovers, GiggedIn and as the Chair of Fame & Partners Pty Ltd until February 2016, supporting the company from startup through to Series A investment.

Anna has over 20 years’ experience leading commercialisation, incubation, investment and business development initiatives in Australia and the UK, and has worked with companies spanning the fields of biotechnology, information technology, and the creative industries. Prior to her relocation to Australia in 2006, she was the Director of the UK’s first National Science City and created the first $1 million ‘proof of principle’ fund in Yorkshire to enable entrepreneurs to exploit their commercial potential.

Anna is passionate about building a vibrant and scalable creative industries sector in Australia. She was a founding partner of the Arts Business Investment Fund (ABIF) in Queensland in 2016 which addresses the need to strengthen income generating and entrepreneurial capacity for non-profit arts and cultural enterprises. ABIF is supported by the Queensland Government and the Tim Fairfax Family Foundation and delivers investment in the form of a grant and no interest loan.

In July 2018, she was appointed as the Managing Director of the Creative Tech Ventures Fund and as a Non-Executive Director of CEA’s Board. She is an authorised representative of CEA’s AFSL.

Anna is also a member of the Advance Queensland Expert Panel, Queensland Startup Committee and a graduate of the Australian Institute of Company Directors.

 
 
brettchenoweth.jpg

Brett Chenoweth | Chairman, QUTCEA

Brett is a former media, digital and telecommunications executive with significant management, boardroom and investment industry experience. Brett has served as Managing Director and Chief Executive Officer of APN News and Media and has held senior executive roles at the Silverfern Group, Telecom New Zealand, Publishing & Broadcasting Limited, ecorp, ninemsn and Village Roadshow Pictures.

Brett is a co-founder of Bombora, an Australian based, high conviction investment company and a senior advisor to the Bombora Special Investments Growth Fund. He is a former Chairman of TMT partners, a NZ based $100m venture capital fund and he established Silverfern Partners in Australia which is a global middle-market, multi-asset class, investment management firm.

Brett is Chairman of Madman Entertainment, Chairman of Yellow Pages Group, Chairman of Canberra Data Centres (CDC), Chairman of Creative Enterprises Australia (CEA), Chairman of the Advisory Board of HRL Morrison & Co., a Principal of the Bombora Group, a Board Director at Surfing Australia, a Director of Sellable, a Director NSW Land Registry, a Director of Saxton and a Director of Janison Education Group.

 
 
 

 Mark Gustowski | CEO, QUTCEA

Mark Gustowski is the CEO of QUT Creative Enterprise Australia and has worked with innovative, fast-growth businesses for over 20 years. A significant portion of that time focussed on equity investments for startups. Mark has been involved in a number of his own startups in the biotech, real-estate tech, edu-tech and FMCG spaces, as well as an angel investor. Mark has supported businesses through the development of B2B and B2C strategies, marketing and sales strategies, IP strategies, channel management and identification, capital raising, corporate structuring and partnering.

As a specialist in supporting high-growth early stage businesses, Mark has designed and delivered investment and accelerator programs across Victoria, the ACT and Queensland and currently sits on the board of three of CEA’s investee companies where he helps steer strategic direction while supporting operational execution. As a founding partner of Zentaurus Investment Management (AFSL 401224) Mark has been involved in investment strategy and structuring (including both Early Stage Venture Capital Limited Partnership (ESVCLP) and Significant Investor Visa (SIV) accreditations), capital brokering and equity investments from the seed to Series-A level. He has worked with Australian governments at all levels on program structure and delivery, policy implementation and investment.

With key experience in Australia, SE Asia, the UK and the US, Mark is passionate about supporting Australian businesses compete in global markets. He has been an Australian Anthill Maven judge, is a Victorian Leaders Forum mentor and following his BAppSci, he also completed the Venture Capital Executives Program at the HAAS Business School (UC Berkeley) on a Victorian Employer’s Chamber of Commerce and Industry (VECCI) scholarship.

 
 
 
Tamara_Mills.JPG

 

Ms. Tamara Mills, MBA, MHEcon, BSc, GAICD | Investment Fund Manager

Tamara Mills is founder and director of a range of emerging technology businesses in Australia and North America including Quantum Innovation Fund Management, an innovation commercialization organization, supporting the growth and development of the Australasian health innovation ecosystem.  Tamara has founded, funded and led a number of companies at the intersection of the creative industries and healthcare, including Glucotek, De Motu Cordis and Fundamedtech (merging fashion, design and science to disrupt current state of care) and has a track record in both successful capital raising and driving asset growth. Tamara’s company Fundamedtech is contracted by leading venture capital groups to advise on investment decisions in the emerging health technology space and Tamara currently sits on the Expert Investment Advisory Committee of Uniseed, conducting investment screening and due diligence on prospective fund assets.

Tamara has over 15 years’ experience in the commercialization of innovative technologies across the United States, Japan, Brazil, Europe and Australia, having held executive level positions within Australia and internationally at both publicly listed and private companies.  Tamara plays an active leadership role within both the national and international start-up ecosystem, working with local organizations to drive commercialisation of  innovation in healthcare and internationally with the Massachusetts Institute of Technology (MIT) supporting founders across diverse sectors, including fashion , consumer technology and life-sciences, to validate, build and scale commercially viable businesses globally.

Prior to returning to Australia Tamara spent six years working in North America managing and re-building Jubilant Life-Sciences Asset Portfolio leading investment screening and due diligence, in-licensing and out-licensing deals from academic institutes through to multinational pharmaceutical and device companies and directing a portfolio of select products for internal development and commercialization. Following on from leading the successful development several of assets within this portfolio Tamara successfully built the Jubilant Life-Sciences cardiovascular business from the ground up and led the development of pharmaceutical and medical technology products from concept through to FDA approval and commercialization.

Tamara has held several board positions across Australia and the US and is a Graduate of the Australian Institute of Company Directors. Tamara has a Masters of Business Administration, Masters in Health Economics, a Bachelor’s Degree in Applied Science and a qualification in New Ventures Leadership from MIT.